Early laboratory results in mice show the drug PXS-5505 increases survival when combined with chemotherapy in the treatment of pancreatic ductal adenocarcinomas.
Click here for original story, Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer
Source: ScienceDaily